West Pharmaceutical Services, Inc. to Join S&P 500 Index
The S&P 500® is a widely regarded index of large-cap U.S. equities
Exton: West Pharmaceutical Services, Inc. has announced that it has been named to the S&P® 500, which will become effective after the close of trading today.
"We are honored to be included with the prestigious group of companies that constitute the S&P® 500," said Eric M. Green, President and Chief Executive Officer. "West is a global healthcare leader in the supply of critical components and products for packaging and delivery of injectable drugs. This recognition represents a significant milestone for West and it further marks the tremendous growth of the Company over the past 97 years. It is also a testament to the accomplishments and dedication of our West team members across the globe."
The S&P 500® is a widely regarded index of large-cap U.S. equities. According to Dow Jones®, there is over $9.9 trillion indexed or benchmarked to the index, with indexed assets comprising approximately $3.4 trillion of this total. The index includes 500 leading companies and covers approximately 80% of available market capitalization.